MRTNZ

MRTNZ Investment Office · S&P 500 · The 360 Vantage

COO · NASDAQ-GS

The Cooper Companies, Inc.

Health Care · Ophthalmic Goods

Reference price$72.06As of Jul 28, 2026
Market capitalization$14.05B
52-week range$58.89–$89.83
S&P 500 portfolio weight0.02%
Data qualitycomplete

Street view

Analyst targets

Published sell-side aggregation—not an MRTNZ forecast.

Low$61.00-15.3% vs. reference
Average$77.60+7.7% vs. reference
High$86.00+19.3% vs. reference
6 Buy4 Hold1 Sell

Forward calendar

Current earnings expectations

Consensus may change until the company reports.

Expected reportAug 26, 2026Jul 2026
Consensus EPS$1.117 estimates
Expected range$1.11–$1.12Low to high EPS
Oct 2026$4.63Street EPS consensus
Oct 2027$4.99Street EPS consensus
Oct 2028$5.45Street EPS consensus

Reported results

Annual financial snapshot

Fiscal period ended Oct 31, 2025.

MetricCurrentPrior
Revenue+5.1% YoY$4.09B$3.9B
Operating income$0.68B$0.71B
Net income$0.37B$0.39B
Operating cash flow$0.8B$0.71B
Capital expenditures($0.36B)($0.42B)

Current context

Related news

Company-linked articles surfaced by Nasdaq.

Zacks

How COO Is Balancing Premium Lens Growth Against Asia-Pacific Risks?

Zacks

Is COO Stock Attractive as MyDay Gains Meet Asia-Pacific Pressure

Zacks

How COO Is Riding Myopia and Fertility Trends Amid Execution Risks

Evidence

Sources & method

Nasdaq quote →Nasdaq summary →Earnings forecast →Annual financials →Official S&P 500-tracking holdings →

Facts, estimates, and scenarios are kept separate. Analyst targets and EPS expectations are third-party estimates, not MRTNZ forecasts. Index weight uses the official IVV portfolio as the denominator. Illustrative research, not investment advice.